⭐ Summit Therapeutics, Inc.  has reportedly been in partnership discussions with  AstraZeneca  and other major pharma companies for its...

📢  AbbVie  is set to acquire  University of Pennsylvania ’s spinout,  Capstan Therapeutics  for up to $2.1 billion in cash, representing...